The latest research from Fore Pharma, ‘US Psychostimulants Market Highlights – 2015’, provides the US Psychostimulants market valuation, competitive landscape, and Psychostimulants products sales in the US. The research includes US Psychostimulants market size estimates for 2014, Psychostimulants products market share, and Psychostimulants products sales estimates. This research helps executives track competitor product sales and market share in the US Psychostimulants market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US Psychostimulants market.
Scope of the Research:
Psychostimulants as defined in EphMRA Anatomical Therapeutic Chemical classification code N6B
Marketed Products: Identify Psychostimulants products marketed including brand name, molecule name, and company
Sales Estimates: Find out estimates for the US Psychostimulants market size in 2014, key products and their sales, and how the market and products advanced from 2011. You will benefit from our accurate sales valuation of products and the market
Competitive Landscape: You will know the market share of leading Psychostimulants products in 2014 and how they have changed from 2011
Pipeline: Find out key Psychostimulants products in clinical trial phase 3 and phase 2. Coverage includes molecule, mechanism of action, and the company developing the product